Blood Group Typing Market Report 2026

Blood Group Typing Market Overview

• Blood Group Typing market size has reached to $3.46 billion in 2025 • Expected to grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Fueling The Blood Group Typing Market The Impact Of Increasing Blood Donations And Transfusions • Market Trend: Next-Generation Sequencing (NGS) and Innovative Solutions in Healthcare • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Blood Group Typing Market?

Blood group typing is a method that tells the type of blood a person has, and it is done so that a person can safely donate blood or receive a blood transfusion. The purpose of blood group typing is to determine an individual’s blood group or blood type by identifying the specific antigens present on the surface of their red blood cells. The main types of blood group typing are antibody screening, cross-matching tests, ABO tests, antigen typing and human leukocyte antigen (HLA) typing. The antibody screening tests are performed in a clinical laboratory or blood bank is done to detect the presence of unexpected antibodies, like alloantibodies in the serum to antigens of the non-ABO blood group system. Cross-matching tests are performed before a blood transfusion as part of blood compatibility testing. Human leukocyte antigen (HLA) typing is a kind of genetic test used to identify certain individual variations or proteins in the immune system. It is often used to match patients and donors for bone marrow or cord blood transplants. ABO tests are done to evaluate the blood type of a person out of four types, which are A, B, AB, or O. Antigen tests are immunoassays that are used to detect the presence of a specific viral antigen and are commonly used in the diagnosis of respiratory pathogens, including influenza viruses and respiratory syncytial virus. The products that are used for blood group typing are instruments, reagents, and kits, and the techniques that are used are serology tests, and molecular tests. Blood group typing is used in hospital-based laboratories, independent laboratories, and blood banks.

What Is The Blood Group Typing Market Growth Forecast?

The blood group typing market size is expected to see rapid growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing adoption of molecular typing techniques, rising demand for rapid compatibility testing, expansion of automated laboratory workflows, growing investments in transfusion safety systems, technological advances in blood group diagnostics. Major trends in the forecast period include increasing adoption of automated blood typing systems, rising demand for high-throughput testing platforms, growing use of molecular blood group typing, expansion of advanced reagent and kit solutions, enhanced focus on transfusion safety.

Global Blood Group Typing Market Segmentation

1) By Test Type: Antibody Screening, Cross-Matching Tests, ABO Tests, Antigen Typing, HLA Typing 2) By Product: Instruments, Reagents And Kits 3) By Techniques: Serology Tests, Molecular Tests 4) By End User: Hospital Based Laboratories, Independent Laboratories And Blood Banks Subsegments: 1) By Antibody Screening: Indirect Coombs Test, Enzyme-Linked Immunosorbent Assay (ELISA) 2) By Cross-Matching Tests: Major Crossmatch, Minor Crossmatch, Electronic Crossmatch 3) By ABO Tests: Forward Typing, Reverse Typing 4) By Antigen Typing: Rh Factor Typing, Kell Typing, Other Blood Group Antigen Typings 5) By HLA Typing: Serological Methods, Molecular Methods (PCR-based)

What Is The Driver Of The Blood Group Typing Market?

The increase in the number of blood donations and transfusions drove the blood group typing market during the historic period. Different nonprofit organizations, government organizations, and other agencies are emphasizing the importance of blood donations and transfusions and spreading awareness through various campaigns. An increase in blood donations increased the demand for blood group typing so that the donor can know what type of blood they have. For instance, in February 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, reported that, in 2024, there are approximately 7 million blood donors and more than 14 million units of blood transfused annually in the United States. The increase in the number of blood donations and transfusions thereby contributed to the growth of the blood typing market.

Key Players In The Global Blood Group Typing Market

Major companies operating in the blood group typing market are Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc., Medion Diagnostics GmbH, ZenTech S.A., BioMedomics Inc., Lifespan Diagnostics LLC

Global Blood Group Typing Market Trends and Insights

Major companies operating in the blood group typing market are developing innovative products with advanced technologies, such as next-generation sequencing (NGS), to enhance the accuracy and efficiency of blood typing processes. NGS enables the detailed analysis of genetic variations in blood group antigens, providing more precise and comprehensive blood group typing. For instance, in April 2023, Metropolis Healthcare Limited, an India-based health company, launched the NextGen HLA Typing Test, which utilizes next-generation sequencing (NGS) technology to enhance the accuracy of human leukocyte antigen (HLA) typing for organ transplantation. This advanced testing method is designed to improve compatibility assessments between donors and recipients, which is crucial for successful transplants.

What Are Latest Mergers And Acquisitions In The Blood Group Typing Market?

In March 2023, Werfen, S.A., a Spain-based company that operates in blood group typing, hemostasis, and transfusion, acquired Immucor Inc. for approximately US$2 billion. Through the acquisition, Werfen increased its footprint as a reference business in the specialized diagnostics market and expanded its offering of diagnostic solutions for hospitals and clinical laboratories. Werfen's current Hemostasis, Acute Care, and Autoimmunity business lines are supplemented by the Transfusion and Transplant product lines, strengthening the company's range. Immucor Inc. is a US-based company specializing in blood group typing.

Regional Outlook

North America was the largest region in the blood group typing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Blood Group Typing Market?

The blood group typing market consists of sale of serology reagents, gel systems, lateral flow rapid technology, and blood group genotyping products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.